The economic burden of multidrug-resistant tuberculosis

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):831-832. doi: 10.5588/ijtld.18.0408.

Authors

Jose A Caminero¹, Anna Scardigli²

Affiliations

¹ Department of Pneumology, University Hospital of Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain, International Union against Tuberculosis and Lung Disease, Paris, France.
² The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.

PMID: 29991388
DOI: 10.5588/ijtld.18.0408

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antitubercular Agents
Cost of Illness*
Humans
Tuberculosis, Multidrug-Resistant*

Substances

Antitubercular Agents